We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fusion Nail for Hindfoot Problems

By HospiMedica staff writers
Posted on 22 Jan 2006
A new hindfoot fusion nail allows surgeons to customize treatment of a lower limb to accommodate the differing needs of patients.

The Trigen hindfoot fusion nail is indicated for degeneration, deformity, or trauma of the hindfoot, including severe pilon fractures, avascular necrosis, and rheumatoid arthritis, as well as failed total ankle replacement and failed ankle arthrodesis. More...
The hindfoot fusion nail is inserted through the heel to keep the ankle in correct position and allow the bones to fuse into a solid structure.

Ankle fusion procedures are typically performed when more conservative options have not produced successful results. The surgical technique is designed to reduce the pain while improving gait for patients. The Trigen hindfoot fusion nail (HFN) is the product of Smith & Nephew Orthopedics (Memphis, TN, USA) and is color-coded for easy implant identification.

"The Trigen HFN is the first intramedullary device to address the actual anatomy of the hindfoot in its design,” said Dr. John Early, an orthopedic surgeon in Dallas (TX, USA). "Its simplified instrumentation and unique locking screw configuration provide me with a new treatment option for difficult surgeries.”





Related Links:
Smith & Nephew

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.